Thursday, 20 June 2019

Drug Discovery News

  • SFJ Pharma, Pfizer collaborate for dacomitinib trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: SFJ Pharmaceuticals, primarily focused on funding and executing phase III studies of drugs, has entered into a collaborative development agreement with Pfizer to conduct a phase ...Read more

  • BMS stops Hepatitis C inhibitor development

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Aug, 2012

    Singapore: Bristol-Myers Squibb has discontinued the development of BMS-986094 (formerly known as INX-189), a nucleotide polymerase (NS5B) inhibitor that was in phase II development for the...Read more

  • FDA approves Bayer thromboembolic BP drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2013

    Singapore: Bayer HealthCare has recieved US FDA approval for Adempas (riociguat) tablets for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension ...Read more

  • FDA red signal for Genzyme, Bayer multiple sclerosis drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2012

    Singapore: Genzyme, a Sanofi company, received a Refuse to File letter from the US FDA in response to the supplemental Biologics License Application (sBLA) for the approval of LEMTRADA (ale...Read more

  • NIH funds $45 mn Alzheimer's drug development

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

    Singapore: The National Institutes of Health (NIH) is funding $45 million for research aimed at preventing Alzheimer's disease and identify and validate biological targets for novel therap...Read more

  • Singapore firm to launch next-gen cancer study device

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2014

    Singapore: Singapore's emerging company Clearbridge BioMedics plans to launch its ClearCell FX System at American Society of Clinical Oncology (ASCO) to be held in Chicago from 30 May to 3 ...Read more

  • CSL files biologics license plea with FDA

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 May, 2012

    Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license application for standard review. The application is for a human 4-factor pr...Read more

  • Japanese biomedical firm sets up lab in Singapore

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

    Singapore: Japan-based biopharmaceutical firm, Kyowa Hakko Kirin (KHK) has setup Singapore Translational Research Laboratory (STRL), an international R&D center in Singapore for biomedi...Read more

  • AB Sciex launches data analysis software

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2013

    Singapore: AB Sciex, a global leader in analytical technologies, has launched MasterView Software, a new software application with built-in automation that turns enormous amounts of complex...Read more

  • LCT conducts first implant of regenerative therapy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

    Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment for Parkinson's disease in the first patient in phase I clinical trial....Read more

  • GSK melanoma phase III misses co-primary endpoint

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

    Singapore: GlaxoSmithKline's (GSK) Dermai study, a phase III, randomized, blinded, placebo-controlled Mage-A3 cancer immunotherapeuticii (CI) trial, which contains Agenus'QS-21 Stimulon adj...Read more

  • Bayer cancer drug Stivarga gets Singapore nod

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: The Health Sciences Authority (HSA) of Singapore has approved Bayer' Stivarga, the first oral targeted therapy proven to extend overall survival in patients with advanced colorec...Read more

  • Eye diseases cost upto $27bn to Europe

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2013

    Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the economic impact of blindness and four leading eye sight conditions. EFA...Read more

  • Gilead hepatitis drug to axe treatment time by half

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2013

    Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-daily oral nucleotide analogue for the treatment of chronic hepatitis ...Read more

  • Gilead leukemia study gets complete response

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2013

    Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta, in combination with rituximab...Read more

  • Advinus collaborates with P2D Bioscience for ADHD

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2012

    Bangalore: Advinus Therapeutics, a Bangalore-based drug discovery and development company, and P2D Bioscience, a CNS-focused specialty pharmaceutical company have initiated a research and d...Read more

  • All you need to know about Glivec

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

    What is Glivec?Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, receptor tyrosine kinase, which is characteristic of a particular can...Read more

  • Cytomegalovirus treatments to improve

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

    Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generally asymptomatic in healthy children and adults, can manifest as a mild...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls